Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FDA approval announcement for ofatumumab
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis.
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis.
Interferon β for secondary progressive multiple sclerosis: a systematic review.
Novel MS Drug Offers Good Functional Outcomes
Alemtuzumab and multiple sclerosis: therapeutic application.
Safety Study of Interferon Beta-1a for Acute Stroke
Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
A full genome search in multiple sclerosis.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Daclizumab discontinue letter for the US market

Pages